Patrick Walsh

Patrick joined Ampersand as an Operating Partner in 2018 and has been CEO of three Ampersand portfolio companies including Alcami, TriPharm Services and Avista Pharma. He currently serves as Chairman of the Board of Alcami and Chairman of the Board of ANI Pharmaceuticals. He has been involved in other Ampersand portfolio companies, serving as Chairman of Brammer Bio and a Director at MedPharm, Ltd. He has extensive experience directing pharmaceutical manufacturing and lab operations on a global scale in fill finish, API, specialty pharmaceutical, formulation, manufacturing, and analytical contract development organizations. Over the course of his 42-year career in the healthcare industry, Patrick has been CEO of six pharma companies and served as a company director in fifteen healthcare organizations.